Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2334

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM) ; volume:20 ; number:1 ; day:15 ; month:1 ; year:2020 ; pages:1-10 ; date:12.2020
BMC infectious diseases ; 20, Heft 1 (15.1.2020), 1-10, 12.2020

Creator: Liégeois, Florian
Boyer, Sylvie
Eymard-Duvernay, Sabrina
Carrieri, Patrizia
Kouanfack, Charles
Domyeum, Jenny
Maradan, Gwenaëlle
Ducos, Jacques
Mpoudi-Ngolé, Eitel
Spire, Bruno
Delaporte, Eric
Kuaban, Christopher
Vidal, Laurent
Laurent, Christian

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12879-020-4784-7

URN: urn:nbn:de:101:1-2020042003362673526280

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liégeois, Florian
Boyer, Sylvie
Eymard-Duvernay, Sabrina
Carrieri, Patrizia
Kouanfack, Charles
Domyeum, Jenny
Maradan, Gwenaëlle
Ducos, Jacques
Mpoudi-Ngolé, Eitel
Spire, Bruno
Delaporte, Eric
Kuaban, Christopher
Vidal, Laurent
Laurent, Christian
SpringerLink (Online service)

Other Objects (12)

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption

Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption

Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption

Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption

Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption

Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption

Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients

Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

Related objects

Reset password